-
1دورية أكاديمية
المؤلفون: Conte P., Frassoldati A., Bisagni G., Brandes A. A., Donadio M., Garrone O., Piacentini F., Cavanna L., Giotta F., Aieta M., Gebbia V., Molino A., Musolino A., Ferro A., Maltoni R., Danese S., Zamagni C., Rimanti A., Cagossi K., Russo A., Pronzato P., Giovanardi F., Moretti G., Lombardo L., Schirone A., Beano A., Amaducci L., Bajardi E. A., Vicini R., Balduzzi S., D'Amico R., Guarneri V.
المساهمون: Conte P., Frassoldati A., Bisagni G., Brandes A.A., Donadio M., Garrone O., Piacentini F., Cavanna L., Giotta F., Aieta M., Gebbia V., Molino A., Musolino A., Ferro A., Maltoni R., Danese S., Zamagni C., Rimanti A., Cagossi K., Russo A., Pronzato P., Giovanardi F., Moretti G., Lombardo L., Schirone A., Beano A., Amaducci L., Bajardi E.A., Vicini R., Balduzzi S., D'Amico R., Guarneri V.
مصطلحات موضوعية: Adjuvant, Breast cancer, Cardiac safety, De-escalated treatment, Trastuzumab, Adult, Aged, Anthracycline, Antineoplastic Agents, Immunological, Antineoplastic Combined Chemotherapy Protocol, Breast Neoplasm, Bridged-Ring Compound, Cardiotoxicity, Chemotherapy, Disease-Free Survival, Drug Administration Schedule, Female, Human, Mastectomy, Middle Aged, Neoplasm Recurrence, Local, Neoplasm Staging, Receptor, ErbB-2, Taxoid, Time Factor, Settore MED/06 - Oncologia Medica
العلاقة: info:eu-repo/semantics/altIdentifier/pmid/30219886; info:eu-repo/semantics/altIdentifier/wos/WOS:000456859200012; volume:29; issue:12; firstpage:2328; lastpage:2333; numberofpages:6; journal:ANNALS OF ONCOLOGY; http://hdl.handle.net/10447/412769Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85059263988
-
2دورية أكاديمية
المؤلفون: Conte P., Frassoldati A., Bisagni G., Brandes A. A., Donadio M., Garrone O., Piacentini F., Cavanna L., Giotta F., Aieta M., Gebbia V., Molino A., Musolino A., Ferro A., Maltoni R., Danese S., Zamagni C., Rimanti A., Cagossi K., Russo A., Pronzato P., Giovanardi F., Moretti G., Lombardo L., Schirone A., Beano A., Amaducci L., Bajardi E. A., Vicini R., Balduzzi S., D'Amico R., Guarneri V.
المساهمون: Conte, P., Frassoldati, A., Bisagni, G., Brandes, A. A., Donadio, M., Garrone, O., Piacentini, F., Cavanna, L., Giotta, F., Aieta, M., Gebbia, V., Molino, A., Musolino, A., Ferro, A., Maltoni, R., Danese, S., Zamagni, C., Rimanti, A., Cagossi, K., Russo, A., Pronzato, P., Giovanardi, F., Moretti, G., Lombardo, L., Schirone, A., Beano, A., Amaducci, L., Bajardi, E. A., Vicini, R., Balduzzi, S., D'Amico, R., Guarneri, V.
مصطلحات موضوعية: Adjuvant, Breast cancer, Cardiac safety, De-escalated treatment, Trastuzumab
وصف الملف: ELETTRONICO
العلاقة: info:eu-repo/semantics/altIdentifier/pmid/30219886; info:eu-repo/semantics/altIdentifier/wos/WOS:000456859200012; volume:29 (12); firstpage:2328; lastpage:2333; numberofpages:6; journal:ANNALS OF ONCOLOGY; http://hdl.handle.net/11567/965565Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85059263988
